17,261 trials
Extrahepatic Bile Duct Cancer · Nausea · Vomiting
Primary: Number of Patients With Gastrointestinal Toxicities (Grade 3 and 4 Nausea and Vomiting) Associated With Delivering Fluorouracil/Gemcitabine Hydrochloride-based…
Coronary Disease · Heart Diseases · Cardiovascular Diseases
Primary: Cognitive Function — 0.07; 0.12 Continuous cognitive change score
Food Hypersensitivity · Hypersensitivity · Immediate Hypersensitivity
Primary: Percent of Participants Who Successfully Consumed 5,000 mg of Peanut Powder or at Least a 10-fold Increase in the Amount of Peanut Powder Compared to Their Baseline Oral…
Burns · Pain
Primary: Overall Pain Trajectory Slopes — -0.22; -0.16 Numeric Rating Scale Score Change/Day
Pain · Diabetic Neuropathy
Primary: Change in Mean Numerical Rating Scale (NRS) Score From Baseline to Last 5 Days of Treatment — -2.33; -2.52 Scores on a scale
Acute Coronary Syndrome
Primary: Adenosine Diphosphate (ADP)-Induced P2Y12 Receptor-Mediated Platelet Aggregation 6 Hours After Prasugrel Loading Dose (LD) — 57.86; 35.61; 53.92 PRU — p=0.188
Chronic Dysphagia · Multiple Sclerosis · Parkinson Disease
Primary: Swallowing Safety for 10 ml of Thin Liquid — 8.417; 7.167; 8.250; 7.375 units on a scale
Breast Cancer
Primary: Change in Serum VEGF in Breast Cancer — 270 pg/ml — p==0.078
Leukemia · Lymphoma · Myelodysplastic Syndromes
Primary: Mean Change in Bone Mineral Density — -0.0714; -0.0036 percent
Kidney Failure, Chronic · Kidney Transplantation · Immunosuppression
Primary: The Proportion of Participants With Graft Loss or Death Within 12 Months Post Kidney Transplantation — 0.057 Proportion of participants
Chronic Obstructive Pulmonary Disease
Primary: FEV1(Forced Expiratory Volume in 1 Second) Measured by Spirometry 5 Minutes Post Dose — 1.072; 1.041; 1.007 percentage change
Colorectal Cancer
Primary: Progression Free Survival — 5.8; 7.2; 7.8 Months
Bacterial Infections · Intra-Abdominal Infection · Pneumonia, Bacterial
Primary: Maximum Observed Plasma Concentration (Cmax) — 456; 1515; 2599 ng/mL
Lymphoma · T-Cell · Cutaneous
Primary: Response Rate — 0; 0; 1; 1 Participants
Osteoporosis
Primary: Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at 12 Months — 7.80; 0.63; 0.32; 1.63 percentage change in BMD — p=<0.001